{"entity":{"type":"insider","cik":"0001733369","url":"/insider/0001733369","json_url":"/insider/0001733369.json","name":"Mehta Vimal","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":19,"first":"2018-11-30","last":"2026-05-22","span_basis":"filed_date"},"name_variants":[{"name":"Mehta Vimal","source":"filing","n_filings":19,"first_seen":"2018-11-30","last_seen":"2026-05-22"}],"transactions":[{"id":5845966,"accession":"0001104659-26-065836","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-065836","line_url":"/filing/0001104659-26-065836#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19419.0,"shares_display":"19,419","price_per_share":1.087,"price_display":"1.09","price_state":"stated","total_value":21108.453,"total_display":"21,108.45","total_whole":"21,108","shares_owned_after":69598.0,"shares_owned_after_display":"69,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-22","scope":"insider"},{"id":2837995,"accession":"0001104659-24-129462","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-129462","line_url":"/filing/0001104659-24-129462","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3117.0,"shares_display":"3,117","price_per_share":0.36293612447866536,"price_display":"0.36","price_state":"stated","total_value":1131.2719,"total_display":"1,131.27","total_whole":"1,131","shares_owned_after":59605.0,"shares_owned_after_display":"59,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-17","scope":"insider","n_lines":2},{"id":2129477,"accession":"0001104659-24-100751","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-100751","line_url":"/filing/0001104659-24-100751","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1982.0,"shares_display":"1,982","price_per_share":0.6896604439959637,"price_display":"0.69","price_state":"stated","total_value":1366.907,"total_display":"1,366.91","total_whole":"1,367","shares_owned_after":51666.0,"shares_owned_after_display":"51,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider","n_lines":2},{"id":3232662,"accession":"0001104659-24-072999","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-072999","line_url":"/filing/0001104659-24-072999#line-3","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2134.0,"shares_display":"2,134","price_per_share":1.2835,"price_display":"1.28","price_state":"stated","total_value":2738.989,"total_display":"2,738.99","total_whole":"2,739","shares_owned_after":47539.0,"shares_owned_after_display":"47,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-18","scope":"insider"},{"id":2146914,"accession":"0001104659-24-069195","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-069195","line_url":"/filing/0001104659-24-069195#line-5","is_derivative":false,"issuer_cik":"0001651990","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001651990","owner_cik":null,"owner_name":"BioXcel LLC; BioXcel Holdings, Inc.; Mehta Vimal","owner_display_name":"BioXcel LLC","owner_url":null,"role":"Director, Officer (CEO and President), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":283122.0,"shares_display":"283,122","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-06","scope":"insider"},{"id":2146910,"accession":"0001104659-24-069195","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-069195","line_url":"/filing/0001104659-24-069195#line-4","is_derivative":false,"issuer_cik":"0001651990","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001651990","owner_cik":null,"owner_name":"BioXcel LLC; BioXcel Holdings, Inc.; Mehta Vimal","owner_display_name":"BioXcel LLC","owner_url":null,"role":"Director, Officer (CEO and President), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126014.0,"shares_display":"126,014","price_per_share":1.5841,"price_display":"1.58","price_state":"stated","total_value":199618.7774,"total_display":"199,618.78","total_whole":"199,619","shares_owned_after":7685501.0,"shares_owned_after_display":"7,685,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-06","scope":"insider"},{"id":2146903,"accession":"0001104659-24-069195","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-069195","line_url":"/filing/0001104659-24-069195#line-3","is_derivative":false,"issuer_cik":"0001651990","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001651990","owner_cik":null,"owner_name":"BioXcel LLC; BioXcel Holdings, Inc.; Mehta Vimal","owner_display_name":"BioXcel LLC","owner_url":null,"role":"Director, Officer (CEO and President), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":609221.0,"shares_display":"609,221","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":7937529.0,"shares_owned_after_display":"7,937,529","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":2146900,"accession":"0001104659-24-069195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-069195","line_url":"/filing/0001104659-24-069195#line-2","is_derivative":false,"issuer_cik":"0001651990","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001651990","owner_cik":null,"owner_name":"BioXcel LLC; BioXcel Holdings, Inc.; Mehta Vimal","owner_display_name":"BioXcel LLC","owner_url":null,"role":"Director, Officer (CEO and President), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":283123.0,"shares_display":"283,123","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":283122.0,"shares_owned_after_display":"283,122","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":2146896,"accession":"0001104659-24-069195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-069195","line_url":"/filing/0001104659-24-069195#line-1","is_derivative":false,"issuer_cik":"0001651990","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001651990","owner_cik":null,"owner_name":"BioXcel LLC; BioXcel Holdings, Inc.; Mehta Vimal","owner_display_name":"BioXcel LLC","owner_url":null,"role":"Director, Officer (CEO and President), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126014.0,"shares_display":"126,014","price_per_share":1.6309,"price_display":"1.63","price_state":"stated","total_value":205516.2326,"total_display":"205,516.23","total_whole":"205,516","shares_owned_after":7811515.0,"shares_owned_after_display":"7,811,515","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-06","scope":"insider"},{"id":2875317,"accession":"0001104659-24-044861","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-044861","line_url":"/filing/0001104659-24-044861","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5268.0,"shares_display":"5,268","price_per_share":2.6239603834472285,"price_display":"2.62","price_state":"stated","total_value":13823.0233,"total_display":"13,823.02","total_whole":"13,823","shares_owned_after":43564.0,"shares_owned_after_display":"43,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider","n_lines":2},{"id":8534179,"accession":"0001104659-23-072396","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-23-072396","line_url":"/filing/0001104659-23-072396","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":20.18337,"price_display":"20.18","price_state":"stated","total_value":605501.1,"total_display":"605,501.10","total_whole":"605,501","shares_owned_after":44916.0,"shares_owned_after_display":"44,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-16","scope":"insider","n_lines":3},{"id":8534164,"accession":"0001104659-23-072396","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-072396","line_url":"/filing/0001104659-23-072396","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":21.540862666666666,"price_display":"21.54","price_state":"stated","total_value":646225.88,"total_display":"646,225.88","total_whole":"646,226","shares_owned_after":47915.0,"shares_owned_after_display":"47,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-16","scope":"insider","n_lines":2},{"id":8224603,"accession":"0001104659-23-064163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-064163","line_url":"/filing/0001104659-23-064163#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":25.7909,"price_display":"25.79","price_state":"stated","total_value":167640.85,"total_display":"167,640.85","total_whole":"167,641","shares_owned_after":37294.0,"shares_owned_after_display":"37,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":8533827,"accession":"0001104659-23-035711","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-23-035711","line_url":"/filing/0001104659-23-035711","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":19.7135,"price_display":"19.71","price_state":"stated","total_value":591405.0,"total_display":"591,405.00","total_whole":"591,405","shares_owned_after":16794.0,"shares_owned_after_display":"16,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-22","scope":"insider","n_lines":2},{"id":8533819,"accession":"0001104659-23-035711","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-23-035711","line_url":"/filing/0001104659-23-035711","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34500.0,"shares_display":"34,500","price_per_share":18.31618608695652,"price_display":"18.32","price_state":"stated","total_value":631908.42,"total_display":"631,908.42","total_whole":"631,908","shares_owned_after":25727.0,"shares_owned_after_display":"25,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-22","scope":"insider","n_lines":4},{"id":6814861,"accession":"0001104659-22-128367","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-22-128367","line_url":"/filing/0001104659-22-128367","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":19.443992333333334,"price_display":"19.44","price_state":"stated","total_value":583319.77,"total_display":"583,319.77","total_whole":"583,320","shares_owned_after":19844.0,"shares_owned_after_display":"19,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-19","scope":"insider","n_lines":2},{"id":6814848,"accession":"0001104659-22-128367","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-128367","line_url":"/filing/0001104659-22-128367","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO and President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":19.939266,"price_display":"19.94","price_state":"stated","total_value":598177.98,"total_display":"598,177.98","total_whole":"598,178","shares_owned_after":17163.0,"shares_owned_after_display":"17,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider","n_lines":2},{"id":5051542,"accession":"0001104659-21-086948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-086948","line_url":"/filing/0001104659-21-086948#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President and Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":473250.0,"shares_display":"473,250","price_per_share":30.8283,"price_display":"30.83","price_state":"stated","total_value":14589492.975,"total_display":"14,589,492.98","total_whole":"14,589,493","shares_owned_after":8546750.0,"shares_owned_after_display":"8,546,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-29","scope":"insider"},{"id":7969941,"accession":"0001104659-19-046520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-046520","line_url":"/filing/0001104659-19-046520#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President and Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":974.0,"shares_display":"974","price_per_share":8.89,"price_display":"8.89","price_state":"stated","total_value":8658.86,"total_display":"8,658.86","total_whole":"8,659","shares_owned_after":9957.0,"shares_owned_after_display":"9,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-19","scope":"insider"},{"id":7777494,"accession":"0001104659-19-046363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-046363","line_url":"/filing/0001104659-19-046363#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2625.0,"shares_display":"2,625","price_per_share":8.67,"price_display":"8.67","price_state":"stated","total_value":22758.75,"total_display":"22,758.75","total_whole":"22,759","shares_owned_after":8983.0,"shares_owned_after_display":"8,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-16","scope":"insider"},{"id":7777492,"accession":"0001104659-19-046363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-046363","line_url":"/filing/0001104659-19-046363#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":358.0,"shares_display":"358","price_per_share":8.44,"price_display":"8.44","price_state":"stated","total_value":3021.52,"total_display":"3,021.52","total_whole":"3,022","shares_owned_after":6358.0,"shares_owned_after_display":"6,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-16","scope":"insider"},{"id":7810508,"accession":"0001104659-19-045931","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-045931","line_url":"/filing/0001104659-19-045931#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President & Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President & Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":8750.0,"total_display":"8,750.00","total_whole":"8,750","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-14","scope":"insider"},{"id":6481170,"accession":"0001104659-18-073106","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-18-073106","line_url":"/filing/0001104659-18-073106","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President, Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.383,"price_display":"4.38","price_state":"stated","total_value":8766.0,"total_display":"8,766.00","total_whole":"8,766","shares_owned_after":3800.0,"shares_owned_after_display":"3,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-14","scope":"insider","n_lines":5},{"id":6221314,"accession":"0001104659-18-071405","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-071405","line_url":"/filing/0001104659-18-071405","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President, Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.12,"price_display":"5.12","price_state":"stated","total_value":5120.0,"total_display":"5,120.00","total_whole":"5,120","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2018-12-04","scope":"insider","n_lines":2},{"id":6496127,"accession":"0001104659-18-071220","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-18-071220","line_url":"/filing/0001104659-18-071220","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President, Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.165,"price_display":"5.16","price_state":"stated","total_value":5165.0,"total_display":"5,165.00","total_whole":"5,165","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-04","scope":"insider","n_lines":5},{"id":6147659,"accession":"0001104659-18-070826","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-070826","line_url":"/filing/0001104659-18-070826","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733369","owner_name":"Mehta Vimal","owner_display_name":"Mehta Vimal","owner_url":"/insider/0001733369","role":"Director, Officer (CEO, President, Secretary)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, President, Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.104,"price_display":"5.10","price_state":"stated","total_value":5104.0,"total_display":"5,104.00","total_whole":"5,104","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-11-30","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":"2018-11-30|6147646","ledger_fault":false,"count":{"value":46,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":46},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001720893","name":"BioXcel Therapeutics, Inc.","url":"/issuer/0001720893","role":"Director, Officer (CEO and President), Ten percent owner","n_filings":19,"first_seen":"2018-11-30","last_seen":"2026-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001733369","retrieved_at":"2026-08-22T23:38:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}